BLOOD PRODUCTS ADVISORY COMMITTEE

September 10-11, 2008

 

REFERENCES

 

 

Topic I: Strategies to Enhance Bacterial Safety of 7 Day Platelets for Transfusion

 

1.      Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadded E, Coakley P. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sanguinis 2008; 95: 13-19.

 

2.      Brecher ME, Means N, Jere CS, Health D, Rothenberg S, Stutzman LS. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion 2001; 41:477-482.

 

3.      Eder AE, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ, the American Red Cross Regional Blood Centers. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47:1134-1142.

 

 

Topic II: Iron Status in Blood Donors

 

1.      Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. Morb Mortal Wkly Rep. 1998; 47 (RR-3):1-36.

 

2.      Looker AC, Cogswell ME, Gunter EW. Iron deficiency, United States, 19992000. Morb Mortal Wkly Rep. 2002; 51(40):897-9.

 

3.      Iron-Status Indicators, National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population 1999-2002. http://www.cdc.gov/nutritionreport/pdf/nr_ch3.pdf

 

4.      Beutler E and Waalen J. The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107(5): 1747-1750.

 

5.      Bianco C et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002; 42: 798-805.

 

6.      Farrugia A. Iron and blood donation: an under-recognized safety issue. Advances in Transfusion Safety (IV) Dev. Biol. Basel, Karger, 2007, vol 127; 137-146.

 

7.      Newman, B. Iron depletion by whole-blood donation harms menstruating females: The current whole-blood-collection paradigm needs to be changed. Transfusion 2006; 46:1667-1681.

 

8.      Brittenham, GM. Iron balance in the red blood cell donor. Advances in Transfusion Safety Dev Biol (Basel). Basel, Karger, 2005, vol 120, 77-82.

 

9.      Magnussen K, Bork N, Asmussen L. The effect of a standardized protocol for iron supplementation to blood donors low in hemoglobin concentration. Transfusion 2008; 48:749-754.

 

 

Topic III: Options for Blood Donor Screening and Reentry for Malaria

1.      Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008 (in press)

 

2.      Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 26: 1973-1978.

 

3.      Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sanguinis 2006; 90:77-84.

 

4.      Elghouzzi MH, Senegas A, Steinmetz T, et al. Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria. Vox Sanguinis 2008; 94: 33-40.

 

5.      Spencer BR, Dedham MA, Custer B, et al. Low risk for malaria transmission from presenting blood donors excluded for travel to Mexico. Transfusion 2006; 46 Supplement: 27 A.

 

6.      FDA Workshop on Testing for Malarial Infections in Blood Donors, July 12, 2006, transcripts and presentations: http://www.fda.gov/cber/blood/malaria071206.htm

 

7.      Kumar, Sanjai. Workshop Summary: Testing for Malarial Infections in Blood Donors. Presented to Blood Products Advisory Committee, July 13, 2006.